Published in Clinical Cancer Research · View the paper (DOI)
A key blood marker of cancer could be used to select the most effective treatment for melanoma, according to an Edith Cowan University study. The discovery has the potential to improve melanoma survival rates by identifying patients who may benefit from more aggressive treatments.
Coverage from 2 institutions